Tema Oncology ETF (CANC) Holdings $25.91 +0.38 (+1.49%) As of 01/30/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrends Top 50 CANC HoldingsRankCompanyCurrent PriceWeightShares Held1AstraZeneca PLCN/A5.71%26,0282BBIOBridgeBio Pharma$35.97-1.3%5.01%84,0253LLYEli Lilly and Company$823.59+2.4%4.29%3,4824MRKMerck & Co., Inc.$98.91+0.6%4.07%26,1785RVMDRevolution Medicines$43.07+5.3%4.01%60,6896GMABGenmab A/S$19.81-0.2%3.76%109,7367RHHBYRoche$39.84+2.5%3.58%58,4808BeiGene, Ltd.N/A3.39%9,4979BPMCBlueprint Medicines$114.05-0.2%3.38%18,15510EXELExelixis$32.93-0.1%3.34%60,811 Get the Latest News and Ratings for CANC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tema Oncology ETF and its competitors with MarketBeat's FREE daily newsletter. 11SMMTSummit Therapeutics$22.36+3.3%3.19%80,50112Daiichi Sankyo Company, LimitedN/A3.02%66,18413Novartis AGN/A2.98%18,62314NUVLNuvalent$87.75+2.6%2.96%21,99415AMGNAmgen$284.02+0.8%2.95%6,59316LEGNLegend Biotech$37.22+3.1%2.88%47,52317Chugai Pharmaceutical Co., Ltd.N/A2.78%41,10918BMYBristol-Myers Squibb$59.11+0.1%2.03%21,39719ILMNIllumina$133.01+1.0%1.99%9,20020ARGXargenx$665.68+1.7%1.96%1,87321GILDGilead Sciences$96.95+1.4%1.90%12,73922ABBVAbbVie$175.54+0.2%1.87%6,80923DAWNDay One Biopharmaceuticals$12.86-1.2%1.77%88,04124MRUSMerus$41.57-0.2%1.73%26,10725IDYAIDEAYA Biosciences$23.88-0.3%1.62%43,27726INCYIncyte$73.77+0.1%1.57%13,45527ACLXArcellx$67.53+4.6%1.56%14,87728JANXJanux Therapeutics$44.79+5.4%1.47%20,45629SWTXSpringWorks Therapeutics$37.23+1.9%1.45%24,95630GHGuardant Health$49.94+4.8%1.42%18,11631LNTHLantheus$92.79+0.3%1.23%7,82432DEPOSITS WITH BROKER FOR SHORT POSITIONSN/A1.20%557,777,99033MREOMereo BioPharma Group$2.931.20%240,87034REGNRegeneron Pharmaceuticals$683.08-0.6%1.12%1,00035AGIOAgios Pharmaceuticals$34.54+2.4%1.11%19,59936CGONCG Oncology$30.15-0.5%1.02%20,53837ARVNArvinas$17.89+1.9%0.96%33,11338EXASExact Sciences$56.03+2.1%0.96%10,86939ORICORIC Pharmaceuticals$10.77-3.4%0.95%57,22640COGTCogent Biosciences$9.62+3.4%0.93%65,376A deadly mistake in my prediction… (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you.41SDGRSchrödinger$25.43+1.9%0.92%23,41342NRIXNurix Therapeutics$20.01+1.8%0.91%28,35743IMCRImmunocore$32.61+3.1%0.74%14,09444ZYMEZymeworks$14.74+0.9%0.72%30,14945RLAYRelay Therapeutics$4.54+1.3%0.64%81,40546CGEMCullinan Therapeutics$10.98-2.4%0.61%35,78347RCUSArcus Biosciences$13.36+2.7%0.60%27,98348CLDXCelldex Therapeutics$25.26-1.0%0.55%13,96349First American Treasury Obligations FundN/A0.45%278,25750AUTLAutolus Therapeutics$2.20+2.8%0.37%100,883 Geographic ExposureUnited States83.5%United Kingdom5.9%Japan5.7%Switzerland3.1%Netherlands1.8%Currency ExposureUSD85.3%GBP5.9%JPY5.7%CHF3.1%Sector ExposureHealth Care66.7%Consumer Discretionary1.4%Industry ExposureBiotechnology59.6%Health Care Equipment & Supplies4.1%Pharmaceuticals3.1%Diversified Consumer Services1.4%SubIndustry ExposureBiotechnology49.8%Pharmaceuticals8.4%Life Sciences Tools & Services2.9%Health Care Equipment1.2%Coupon Exposure4-60.5%Maturity Exposure15-200.5% Related Companies and Tools Related Companies Global X Data Center & Digital Infrastructure ETF Portfolio Companies Tradr 2X Long Innovation ETF Portfolio Companies Fidelity Disruptive Communications ETF Portfolio Companies Global X Aging Population ETF Portfolio Companies CrossingBridge Pre-Merger SPAC ETF Portfolio Companies Siren Nasdaq NexGen Economy ETF Portfolio Companies Procure Space ETF Portfolio Companies Fidelity Disruptive Medicine ETF Portfolio Companies Tradr 2X Short Innovation Daily ETF Portfolio Companies Tema Cardiovascular and Metabolics ETF Portfolio Companies This page (NASDAQ:CANC) was last updated on 1/31/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Oncology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Oncology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CANC Stock Alerts